Low expression of ANXA1 has been confirmed in breast cancer tumor tissues, but there is still overexpressing ANXA1 in poorly differentiated, invasive tumors [13], therefore, it is crucial to further clarify the roles and mechanisms between ANXA1 and malignancies. This evidence concerns the gene ANXA1 and breast carcinoma.